A citation-based method for searching scientific literature

Young Shin Song, Jung Ah Lim, Hoonsung Choi, Jae-Kyung Won, Jae Hoon Moon, Sun Wook Cho, Kyu Eun Lee, Young Joo Park, Ka Hee Yi, Do Joon Park, Jeong-Sun Seo. Cancer 2016
Times Cited: 89



Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, Young Kee Shong, Tae Yong Kim, David Viola, Rossella Elisei, Bela Bendlová, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle, Eyal Robenshtok, James A Fagin, Efisio Puxeddu, Laura Fugazzola, Agnieszka Czarniecka, Barbara Jarzab, Christine J O'Neill, Mark S Sywak, Alfred K Lam, Garcilaso Riesco-Eizaguirre, Pilar Santisteban, Hirotaka Nakayama, Roderick Clifton-Bligh, Giovanni Tallini, Elizabeth H Holt, Vlasta Sýkorová. J Clin Oncol 2015
Times Cited: 296




List of shared articles



Times cited

TERT promoter mutations and long-term survival in patients with thyroid cancer.
Tae Hyuk Kim, Young-Eun Kim, Soomin Ahn, Ji-Youn Kim, Chang-Seok Ki, Young Lyun Oh, Kyunga Kim, Jae Won Yun, Woong-Yang Park, Jun-Ho Choe,[...]. Endocr Relat Cancer 2016
46

A meta-analysis of prognostic roles of molecular markers in papillary thyroid carcinoma.
Huy Gia Vuong, Uyen N P Duong, Ahmed M A Altibi, Hanh T T Ngo, Thong Quang Pham, Hung Minh Tran, Greta Gandolfi, Lewis Hassell. Endocr Connect 2017
34

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
80

Differences in Gene Expression Profile of Primary Tumors in Metastatic and Non-Metastatic Papillary Thyroid Carcinoma-Do They Exist?
Sylwia Szpak-Ulczok, Aleksandra Pfeifer, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Malgorzata Kowalska, Tomasz Tyszkiewicz, Marta Cieslicka, Daria Handkiewicz-Junak, Krzysztof Fujarewicz, Dariusz Lange,[...]. Int J Mol Sci 2020
3

BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence.
Agnieszka Czarniecka, Małgorzata Oczko-Wojciechowska, Marcin Barczyński. Gland Surg 2016
33

Molecular Markers Involved in Tumorigenesis of Thyroid Carcinoma: Focus on Aggressive Histotypes.
Gustavo C Penna, Fernanda Vaisman, Mario Vaisman, Manuel Sobrinho-Simões, Paula Soares. Cytogenet Genome Res 2016
32

A six-genotype genetic prognostic model for papillary thyroid cancer.
Xiaopei Shen, Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2017
41

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults.
Kepal N Patel, Linwah Yip, Carrie C Lubitz, Elizabeth G Grubbs, Barbra S Miller, Wen Shen, Peter Angelos, Herbert Chen, Gerard M Doherty, Thomas J Fahey,[...]. Ann Surg 2020
72

Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
Dagmara Rusinek, Ewa Chmielik, Jolanta Krajewska, Michal Jarzab, Malgorzata Oczko-Wojciechowska, Agnieszka Czarniecka, Barbara Jarzab. Int J Mol Sci 2017
19

Role of molecular markers to predict distant metastasis in papillary thyroid carcinoma: Promising value of TERT promoter mutations and insignificant role of BRAF mutations-a meta-analysis.
Huy Gia Vuong, Ahmed Ma Altibi, Uyen Np Duong, Hanh Tt Ngo, Thong Quang Pham, Hung Minh Tran, Naoki Oishi, Kunio Mochizuki, Tadao Nakazawa, Lewis Hassell,[...]. Tumour Biol 2017
23

Application of molecular biology of differentiated thyroid cancer for clinical prognostication.
Vincenzo Marotta, Concetta Sciammarella, Annamaria Colao, Antongiulio Faggiano. Endocr Relat Cancer 2016
19


The Combination of RET, BRAF and Demographic Data Identifies Subsets of Patients with Aggressive Papillary Thyroid Cancer.
Jose R W Martínez, Sergio Vargas-Salas, Soledad Urra Gamboa, Estefanía Muñoz, José Miguel Domínguez, Augusto León, Nicolás Droppelmann, Antonieta Solar, Mark Zafereo, F Christopher Holsinger,[...]. Horm Cancer 2019
4

How limited molecular testing can also offer diagnostic and prognostic evaluation of thyroid nodules processed with liquid-based cytology: Role of TERT promoter and BRAF V600E mutation analysis.
Marco Dell'Aquila, Vincenzo Fiorentino, Maurizio Martini, Sara Capodimonti, Tonia Cenci, Celestino Pio Lombardi, Marco Raffaelli, Alfredo Pontecorvi, Guido Fadda, Liron Pantanowitz,[...]. Cancer Cytopathol 2021
0

Molecular Profile of Locally Aggressive Well Differentiated Thyroid Cancers.
Leila J Mady, Michael C Grimes, Nayel I Khan, R Harsha Rao, Simion I Chiosea, Linwah Yip, Robert L Ferris, Yuri E Nikiforov, Sally E Carty, Umamaheswar Duvvuri. Sci Rep 2020
2


Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.
Carles Zafon, Juan J Díez, Juan C Galofré, David S Cooper. Eur Thyroid J 2017
8


Mutations of the TERT promoter are associated with aggressiveness and recurrence/distant metastasis of papillary thyroid carcinoma.
Riming Liu, Yulan Li, Weixin Chen, Jianglin Cong, Zhengfang Zhang, Li Ma, Lina Chu, Hui Xiao, Yanhong Zhang, Yongming Liu,[...]. Oncol Lett 2020
1

TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower 131 i uptake in metastases.
Zhaowei Meng, Michiko Matsuse, Vladimir Saenko, Shunichi Yamashita, Peng Ren, Xiangqian Zheng, Qiang Jia, Jian Tan, Ning Li, Wei Zheng,[...]. IUBMB Life 2019
5

Role and relevance of BRAF mutations in risk stratifying patients of papillary thyroid cancers along with a review of literature.
A Krishnamurthy, V Ramshankar, K Murherkar, S Vidyarani, G C Raghunandhan, A Das, P B Desai, K Albert. Indian J Cancer 2017
4

Genetic-guided Risk Assessment and Management of Thyroid Cancer.
Mingzhao Xing. Endocrinol Metab Clin North Am 2019
18